Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia
暂无分享,去创建一个
[1] C. Junien,et al. A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32. , 1999, American journal of human genetics.
[2] J. Slack. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. , 1969, Lancet.
[3] T. Farag. Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.
[4] O. Rødningen,et al. Application of long polymerase chain reaction in the study of the LDL receptor gene. , 1996, Scandinavian Journal of Clinical and Laboratory Investigation.
[5] N. Seidah,et al. Biosynthesis and Cellular Trafficking of the Convertase SKI-1/S1P , 2002, The Journal of Biological Chemistry.
[6] I. Shimomura,et al. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. , 1999, Current opinion in lipidology.
[7] O. Faergeman,et al. Detection of the apoB-3500 mutation (glutamine for arginine) by gene amplification and cleavage with MspI. , 1991, Journal of lipid research.
[8] R. Krauss,et al. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. , 1990, Journal of lipid research.
[9] M. Skolnick,et al. Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[10] J. Slack. RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES , 1969 .
[11] The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society. , 1988, European heart journal.
[12] J. Breslow,et al. Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mices⃞s⃞ The online version of this article (available at http://www.jlr.org) contains one supplemental table. Published, JLR Papers in Press, August 1, 2003. DOI 10.1194/jlr.M300203-JLR200 , 2003, Journal of Lipid Research.
[13] M. Hørder,et al. Characterization of two isoalleles and three mutations in both isoforms of purified recombinant human porphobilinogen deaminase , 2005, Scandinavian journal of clinical and laboratory investigation.
[14] J. Weissenbach,et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia , 2003, Nature Genetics.
[15] J. Sparks,et al. Liver regrowth and apolipoprotein B secretion by rat hepatocytes following partial hepatectomy. , 1994, Metabolism: clinical and experimental.
[16] M. Brown,et al. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. Prat,et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. Humphries,et al. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. , 2003, Atherosclerosis.